Latest / Stuff Mom Never Told You / SMNTY Interviews: Dr. Sika Dedo
Transcript
- 0:05Speaker 1: Hey, this is Anny and Samantha. I'm what kind of
- 0:07Speaker 1: stuff I never told your production of iHeartRadio.
- 0:18Speaker 2: And y'all, I'm so excited because I think we've been
- 0:21Speaker 2: working on this episode for a minute, especially like in
- 0:24Speaker 2: my head, because we are bringing on one of my
- 0:27Speaker 2: good friends who has done an amazing amount of work
- 0:31Speaker 2: and recently graduated with her doctorate. Yes, doctor, she is
- 0:36Speaker 2: a doctor, and we must celebrate all those things. We
- 0:39Speaker 2: are bringing on doctor Sika Debt. Oh, we're gonna call
- 0:43Speaker 2: her doctor Debto, although sometimes you know, I might call
- 0:46Speaker 2: her by Ceci because we close like that, right, CEC. Absolutely,
- 0:52Speaker 2: But for this episode, you have earned that title of
- 0:55Speaker 2: doctor Debto because you have done so much amazing work
- 0:59Speaker 2: and I'm so exc to talk about the research that
- 1:01Speaker 2: you have been doing and has finished.
- 1:04Speaker 3: But it's never finished. Let's just be real honest, right.
- 1:06Speaker 2: But first, before we get into it, because obviously I'm
- 1:08Speaker 2: jumping ahead because I'm too excited about this episode, can
- 1:11Speaker 2: you introduce yourself for our listeners?
- 1:14Speaker 4: Thank you so much, Samantha for the introduction. I would
- 1:17Speaker 4: love to introduce myself. Hello everyone, my name is doctor
- 1:21Speaker 4: Sika or Ccdetto, and I'm really happy to be here
- 1:24Speaker 4: with you today. Samantha. You are right. We've been talking
- 1:28Speaker 4: about this for a while, and I'm excited to finally
- 1:31Speaker 4: share a bit more about my work and my journey.
- 1:34Speaker 4: My academic focus centers on maternal health and public health,
- 1:38Speaker 4: and my dissertation explored antenato care utilization and HIV AIDS
- 1:43Speaker 4: awareness among women of reproductive agent Senegal. So really quickly,
- 1:48Speaker 4: I want to give you key definitions. Intonato care refers
- 1:52Speaker 4: to the routine healthcare women receive you during pregnancy, including
- 1:56Speaker 4: medical checkups, health education, screenings, and support aimed at ensuring
- 2:01Speaker 4: the health and well being of both the mother and
- 2:03Speaker 4: the baby and women of reproductive age. And the study
- 2:07Speaker 4: is the finest women between the ages of fifteen to
- 2:10Speaker 4: forty nine years old. I mentioned that my dissertation topics.
- 2:14Speaker 4: I recently graduated in December from Georgia State University located
- 2:18Speaker 4: in Atlanta with my doctorate of Public Health. I started
- 2:22Speaker 4: the program in twenty twenty one and I graduated in
- 2:27Speaker 4: twenty twenty five. So for beautiful years working to receive
- 2:34Speaker 4: my degree, which I'm very proud of and very excited about.
- 2:38Speaker 4: And as you know, Samantha, who I've been talking to
- 2:41Speaker 4: you about this dissertation for a while now. So I
- 2:46Speaker 4: also want to give some information about who I am.
- 2:49Speaker 4: Who is this person speaking with you today. So I
- 2:52Speaker 4: come from both Togo, a beautiful country located in West Africa,
- 2:56Speaker 4: and the United States. My father is Total Lees and
- 3:00Speaker 4: my mother is from here. Tog is a western country
- 3:06Speaker 4: bordered by Ghana, Benin and Burkina Faso. I lived in
- 3:10Speaker 4: Togo for the first six years of my life, and
- 3:12Speaker 4: after that my family and I relocated to the US
- 3:16Speaker 4: and we continue to visit Togo regularly thereafter, which really
- 3:19Speaker 4: allowed me to maintain strong cultural and personal ties that
- 3:23Speaker 4: really continue to inform my work in perspective in public health.
- 3:28Speaker 4: Living in Togo and visiting regularly has deeply shaped how
- 3:32Speaker 4: I see health, culture and access to care across different settings.
- 3:37Speaker 4: I selected Senegal for my dissertation because of its unique
- 3:41Speaker 4: public health landscape, its regional importance in West Africa, and
- 3:45Speaker 4: the valuable lessons it offers for improving maternal and HIV
- 3:49Speaker 4: related health outcomes. Senegal is a success story for HIV.
- 3:53Speaker 4: They have a very low prevalence rate under one percent.
- 3:57Speaker 4: For those who may not know, Senegal is located on
- 4:00Speaker 4: the western coast of Africa along the Atlantic Ocean, and
- 4:03Speaker 4: it's bordered by Mauritania to the north, Molly to the east,
- 4:07Speaker 4: Guinea and Guinea Bissau to the south. In the Gambia,
- 4:10Speaker 4: which is almost entirely surrounded by Senegal, Senegal plays a
- 4:15Speaker 4: key role in public health research in the region. I'm
- 4:18Speaker 4: looking forward to this conversation into sharing insights, experiences and
- 4:22Speaker 4: ideas with you all.
- 4:24Speaker 2: And it's such a big topic. I remember when you
- 4:27Speaker 2: were telling me about your work. I had to kind
- 4:29Speaker 2: of stop you and look at you real straight, like wait, wait,
- 4:32Speaker 2: back up, back up. I need to hear more clarification
- 4:35Speaker 2: about your work because it was so amazing, like it's
- 4:39Speaker 2: so needed. But it's very like concentrated you have, which
- 4:44Speaker 2: is probably why you doctor Ebody. You had so much
- 4:47Speaker 2: in this research. You traveled for this research, You've done
- 4:50Speaker 2: so much data, and you did so much work within
- 4:54Speaker 2: the field that I was like, oh my god, this
- 4:56Speaker 2: is amazing.
- 4:57Speaker 3: We have to talk about it. And when you were
- 4:59Speaker 3: telling me.
- 5:00Speaker 2: About your research, you sit us like your outline and
- 5:05Speaker 2: so I'm going to read the title here. Make sure
- 5:07Speaker 2: I get this right, okay, doctor Detta, make sure I
- 5:09Speaker 2: am clarifying in the title saying looking at antenatal care
- 5:14Speaker 2: and knowledge of HIV transmission among reproductive age of women
- 5:18Speaker 2: in Senegal.
- 5:19Speaker 4: Correct, Yes, that is correct? All right?
- 5:22Speaker 3: Can you tell us what this is?
- 5:26Speaker 4: Absolutely I'll be happy to share more about my research
- 5:30Speaker 4: as discussed. I've been engaged in this type of research
- 5:32Speaker 4: for over sixteen years and this work was conducted from
- 5:36Speaker 4: my Doctor of Public Health dissertation at Georgia State University
- 5:40Speaker 4: and it focuses on two closely connected areas INTNADO care
- 5:44Speaker 4: utilization and knowledge of HIV transmission among women of reproductive
- 5:49Speaker 4: age and Senegal. I'll start with intonado care, often referred
- 5:53Speaker 4: to as A and C. An C is incredibly important
- 5:57Speaker 4: because the timing and the number of visits during pregnancy
- 6:00Speaker 4: can significantly affect the health and well being of both
- 6:03Speaker 4: the mother and the baby. For pregnant women, and C
- 6:07Speaker 4: is the main entry point into the healthcare system. It's
- 6:11Speaker 4: really where they receive medical care, health education, screening, and support,
- 6:16Speaker 4: including services that help prevent mother to child transmission of HIV.
- 6:21Speaker 4: So the World Health Organization recommends eight or more intonatal
- 6:24Speaker 4: care visits, with the first visit occurring during the first trimester.
- 6:29Speaker 4: Of pregnancy. Research shows that when women receive adequate and
- 6:33Speaker 4: timely AC outcomes improve. These visits help the health providers
- 6:39Speaker 4: identify and treat complications early, and evidence suggests that having
- 6:43Speaker 4: eight or more visits can reduce perinatal mortality. So, really, overall,
- 6:49Speaker 4: an C plays a critical role in supporting healthy pregnancies
- 6:52Speaker 4: and healthy births. The second part of my research focuses
- 6:56Speaker 4: on HIV AIDS awareness and knowledge of HIV transmission. Awareness
- 7:02Speaker 4: of HIV in understanding how it is and is not transmitted.
- 7:07Speaker 4: Both of those are key to prevention. Research consistently shows
- 7:11Speaker 4: that knowledge of HIV transmission pathways influences health behavior, while
- 7:16Speaker 4: limited understanding of HIV prevention contributes to ongoing transmission. In
- 7:22Speaker 4: this study, to measure HIV knowledge, the study used five
- 7:26Speaker 4: key questions that together define what's known as comprehensive knowledges
- 7:31Speaker 4: of HIV. These questions assess whether individuals understand accurate modes
- 7:36Speaker 4: of transmission and also can reject common misconceptions. For example,
- 7:44Speaker 4: participants were asked whether consistent condom use can reduce the
- 7:48Speaker 4: risk of HIV, whether having one uninfected and faithful partner
- 7:52Speaker 4: lowest risk, whether HIV can be transmitted through mosquito bites
- 7:56Speaker 4: or sharing food, and whether a person who looks healthy
- 7:59Speaker 4: can still have hip. As you can see, this research
- 8:03Speaker 4: is robust and there's a deeper dive I can take
- 8:07Speaker 4: into each section, but I will pass it over to
- 8:10Speaker 4: you and see if you have any other questions.
- 8:12Speaker 2: For me, I want to back up just real quick,
- 8:14Speaker 2: because you said you've been in this public health bold
- 8:16Speaker 2: for sixteen years and then you jumped into this.
- 8:18Speaker 3: How did you get into all of this?
- 8:21Speaker 4: That's a great question, and for me, this type of
- 8:23Speaker 4: research is deeply personal. My interest in public health and
- 8:28Speaker 4: global health really began with my lived experiences. Like I
- 8:31Speaker 4: said earlier, I spent the first six years of my
- 8:33Speaker 4: life in Togo, and after that my family and I
- 8:36Speaker 4: continue to visit to go regularly, and being immersed in
- 8:40Speaker 4: that environment gave me an early and very real understanding
- 8:43Speaker 4: of health and how health is shaped not only by
- 8:47Speaker 4: our biology, but by where you live, your resources, your education,
- 8:52Speaker 4: and your access to care. During that time, my family
- 8:57Speaker 4: experienced a loss of a loved one as we went
- 8:59Speaker 4: back in for if. I think I was about as
- 9:01Speaker 4: a teenager at that time, and that moment was pivotal
- 9:04Speaker 4: for me. It raised so many questions. I have questions
- 9:08Speaker 4: about the health system's access to care, prevention, and why
- 9:11Speaker 4: outcomes can look very different depending on the context. This
- 9:17Speaker 4: pushed me to start asking deeper health questions and I
- 9:21Speaker 4: started to look beyond like someone's individual behavior and I
- 9:25Speaker 4: took a broader approach to what shades health outcomes. That's
- 9:31Speaker 4: really when I began to understand and connect the concept
- 9:34Speaker 4: of the social determinants of health and the social determinants
- 9:39Speaker 4: of health. It's the idea that there are factors like income, education, culture,
- 9:45Speaker 4: health access, geography, factors like that they really play a
- 9:51Speaker 4: major role in one's health and well being. I personally
- 9:57Speaker 4: saw fer ashand how these social detail perminents impact my
- 10:03Speaker 4: family's health. During my academic journey at Georgia State, I
- 10:07Speaker 4: knew I wanted to focus on making a difference, and
- 10:11Speaker 4: I particularly wanted to focus on HIV AIDS and I
- 10:16Speaker 4: wanted to emphasize women because I feel like their voices
- 10:21Speaker 4: and experiences are often underrepresented in research. That desire really
- 10:27Speaker 4: led me to study Antennado care utilization and HIV AIDS
- 10:32Speaker 4: awareness and knowledge of HIVH transmission among this population of
- 10:38Speaker 4: women in Senegal. This research really allowed me to explore
- 10:42Speaker 4: how access to care, knowledge, and structural factors intersect, and
- 10:46Speaker 4: how strengthening systems and education can lead to better health outcomes. Altimately,
- 10:53Speaker 4: this work is about more than data. For me, It's
- 10:56Speaker 4: about honoring lived experiences, addressing inequities, and contributing to solutions
- 11:01Speaker 4: that are informed by evidence, culture, and compassion. That's what
- 11:04Speaker 4: continues to motivate me and guide me through my work
- 11:08Speaker 4: and public health and global health.
- 11:11Speaker 3: That's amazing.
- 11:12Speaker 2: I'm sorry for your loss, but I love that that
- 11:14Speaker 2: grew into a passion. Obviously with you doing such important work,
- 11:19Speaker 2: because when you were talking about how Senegal did have
- 11:23Speaker 2: a successful story, it's obvious that you are looking at
- 11:26Speaker 2: this as a broader picture.
- 11:28Speaker 3: Am I correct?
- 11:29Speaker 4: Absolutely, yes, I definitely am.
- 11:32Speaker 2: How would that translate into worldwide care?
- 11:36Speaker 4: That's an important question and it's one that I thought
- 11:38Speaker 4: about a lot while conducting this research. While my research
- 11:42Speaker 4: focuses on Senegal, the issues that examines, which are access
- 11:47Speaker 4: to INSINATO care and knowledge is HIV transmission. There are
- 11:51Speaker 4: global challenges and they're not limited to a single country. Really, like,
- 11:56Speaker 4: at its core value, this research highlights how early adequate
- 11:59Speaker 4: and in tonato care can serve as a powerful entry
- 12:03Speaker 4: point and so health care system for women everywhere around
- 12:07Speaker 4: the world. INTNATO care is often where women first receive
- 12:11Speaker 4: health education, screening, and preventing services. The patterns we see
- 12:16Speaker 4: in Senegal, such as the impact of the timing and
- 12:19Speaker 4: frequency of visits and access barriers, they mirror what we
- 12:23Speaker 4: see in many low to middle income settings. These fightings
- 12:30Speaker 4: they reinforce the idea that strengthening maternal health systems has
- 12:34Speaker 4: ripple effects far beyond pregnancy alone, and for the HIV
- 12:39Speaker 4: component of the research, this also translates globally. Knowledge of
- 12:45Speaker 4: HIV transmission and the ability to reject common misconceptions is
- 12:49Speaker 4: a key driver of health behavior everywhere. Whether it's in Senegal,
- 12:53Speaker 4: whether it's in other countries in West Africa or elsewhere
- 12:57Speaker 4: in the world, misinformation can increase, while accurate knowledge empowers
- 13:02Speaker 4: people to protect themselves and their families. Senegal success in
- 13:06Speaker 4: HIV prevention offers lessons that can be adapted globally, particularly
- 13:10Speaker 4: around integrating education into routine health services like Intinado care.
- 13:16Speaker 4: Also another way this research translates worldwide is it's focused
- 13:20Speaker 4: on the social determinants of health, so we know these
- 13:23Speaker 4: are factors such as education, social economic status, geography, and
- 13:28Speaker 4: health systems access. All of these influenced outcomes no matter
- 13:32Speaker 4: where you resign. When we are identifying how these determinant
- 13:37Speaker 4: shape intenado care use, and HIV knowledge and senegal the
- 13:42Speaker 4: research really provides a framework that policymakers, practitioners, public health specialists, researchers,
- 13:50Speaker 4: and other stakeholders how they can apply these in the
- 13:54Speaker 4: context to identify gaps and design more equitable interventions. Over All,
- 13:59Speaker 4: this research shows that I'm improving maternal health and HIV
- 14:03Speaker 4: outcomes isn't just about individuals choices, It's about systems. When
- 14:07Speaker 4: health systems are accessible, culturally responsive and grounded and evidence
- 14:12Speaker 4: they can support healthier outcomes for women and families everywhere.
- 14:16Speaker 1: Yes, and it really is a lot to consider when
- 14:20Speaker 1: you're looking at different populations and communities, and I imagine
- 14:25Speaker 1: that that can take a while to consider all of
- 14:27Speaker 1: those things. How long have you been doing this research?
- 14:32Speaker 4: So I started the research in twenty twenty three and
- 14:37Speaker 4: I completed it in twenty twenty five, so a little
- 14:40Speaker 4: over two years.
- 14:42Speaker 1: Let's not do bad comfort a lot of ground in
- 14:44Speaker 1: two years.
- 14:46Speaker 2: I mean, that's still a lot of work obviously, because
- 14:48Speaker 2: I know when I was talking to you throughout the process,
- 14:51Speaker 2: You're like, I have to redo this, I have to
- 14:52Speaker 2: revamp this, I have to redo this, Like I don't
- 14:55Speaker 2: like every weekend was like, oh my god, I have
- 14:56Speaker 2: to stay up to do this and this. So I
- 14:58Speaker 2: already know the amount of work that you had to
- 15:01Speaker 2: put in there, but still you are fast tracking in
- 15:04Speaker 2: your own like getting it out there, which is impressive.
- 15:09Speaker 2: Which is so impressive when you look at the scale
- 15:11Speaker 2: of work, and you kind of already talked about some
- 15:14Speaker 2: of this. But let's talk about with your dissertation being presented,
- 15:18Speaker 2: was there a result of this research.
- 15:20Speaker 4: Of course, I'm more than happy to discuss that with
- 15:23Speaker 4: you quickly. I would like to rewind and discuss the
- 15:27Speaker 4: objectives and clearly state what each objective is. So I
- 15:31Speaker 4: had three research objectives. The objective for the first piece
- 15:36Speaker 4: is to look at Incinato care intensity. This was looking
- 15:40Speaker 4: at the number of times a woman receives her Intonado
- 15:44Speaker 4: care visits and we're looking for eight or more. As
- 15:47Speaker 4: you recall, the World Health Organization recommends that women receive
- 15:50Speaker 4: eight or more visits. The second objective is also related
- 15:54Speaker 4: to Intonato care and we're looking at the timing of
- 15:56Speaker 4: the first visit. You also recall that I'm mentioned earlier
- 16:01Speaker 4: that the World Health Organization recommends that the first visit
- 16:04Speaker 4: occur within the first trimester of pregnancy. The third objective
- 16:09Speaker 4: is for HIV AIDS awareness and knowledge of HIV prevention.
- 16:15Speaker 4: This was assessed by asking respondents questions such as, have
- 16:19Speaker 4: you ever heard of HIV or AIDS? Can people reduce
- 16:24Speaker 4: their chance of getting HIV by using a condom every
- 16:26Speaker 4: time they have sex? HIV is a virus that can
- 16:30Speaker 4: lead to AIDS. Can people reduce their chance of getting
- 16:32Speaker 4: HIV by having just one unaffected sex partner who has
- 16:36Speaker 4: no other sex partners? Can people get HIV from mosquito bites?
- 16:40Speaker 4: Can people get HIV by sharing food with a person
- 16:42Speaker 4: who has HIV? Is it possible for a healthy looking
- 16:46Speaker 4: person to have HIV? So these types of questions were
- 16:49Speaker 4: asked and responses determine one's level of knowledge of HIV
- 16:56Speaker 4: transmission and one's awareness of HIV AIDS. So this brings
- 17:00Speaker 4: me to your initial question discussion of my results. When
- 17:05Speaker 4: I analyzed the results, one of my main goals was
- 17:07Speaker 4: to understand which factors were meaningfully associated with intinnatal care
- 17:11Speaker 4: use and knowledge of HIV transmission. In other words, which
- 17:15Speaker 4: relationships were statistically significant and not happening by chance. Starting
- 17:21Speaker 4: with INTONADO care. The results showed some important patterns. I
- 17:25Speaker 4: will highlight a couple of them. It showed that women
- 17:29Speaker 4: with higher education, greater wealth, and women who were employed
- 17:33Speaker 4: within the previous year were significantly more likely to attend
- 17:37Speaker 4: eight or more visits, and these factors stood out even
- 17:41Speaker 4: when other variables were taken into account. We know that
- 17:44Speaker 4: education plays a key role in early access to care.
- 17:48Speaker 4: Women who were more educated and women whose husbands or
- 17:51Speaker 4: partners at higher levels of education were more likely to
- 17:54Speaker 4: begin INTNATO care in their first trimester, which is crucial.
- 17:59Speaker 4: It's really critical for identifying and managing potential complications early
- 18:03Speaker 4: in pregnancy. I also look closely at knowledge of HIV
- 18:06Speaker 4: transmission and awareness of HIV AIDS, because awareness and accurate
- 18:10Speaker 4: information are both essential to prevention. Across nearly all measures
- 18:15Speaker 4: of HIV knowledge, education and wealth consistently mattered. For example,
- 18:22Speaker 4: women who were more educated, wealthier, literate, and implored had
- 18:25Speaker 4: higher odds of knowing that consistent condom use reduces the
- 18:29Speaker 4: risk of HIV transmission. When I focus specifically on women
- 18:33Speaker 4: who had recently given birth, younger age, along with education, wealth,
- 18:37Speaker 4: and employment was also associated with the higher levels of
- 18:41Speaker 4: this knowledge. I saw similar patterns emerging when I looked
- 18:44Speaker 4: at knowledge related to having one uninfected sexual partner as
- 18:49Speaker 4: a way to reduce HIV risks among all women. Increased education, wealth,
- 18:54Speaker 4: and employment were linked to better understanding of HIV transmission
- 19:00Speaker 4: women with recent births, those who were younger, more educated,
- 19:03Speaker 4: and wealthier had higher odds of this knowledge. So overall,
- 19:08Speaker 4: we see patterns that really show us that social determinants
- 19:11Speaker 4: of health, social demographic factors, they all impact health knowledge wellbeing.
- 19:20Speaker 4: So what does this all mean? The takeaway I would
- 19:23Speaker 4: say is social and economic factors matter, and they matter
- 19:27Speaker 4: a lot. Access to education, financial stability, and employment consistently
- 19:32Speaker 4: shape both the use of INTNADO care and knowledge of
- 19:36Speaker 4: HIV prevention. From a public health perspective, this tells us
- 19:41Speaker 4: that increasing intonado care utilization requires intentional and strategic efforts
- 19:46Speaker 4: that address the needs of the most disadvantaged populations, particularly
- 19:51Speaker 4: across access, availability, and timing of services. It also shows
- 19:57Speaker 4: that improving HIV awareness isn't just about delivering it information
- 20:00Speaker 4: but about addressing the broader social determinants of health, all
- 20:04Speaker 4: while respecting the cultural contexts. Ultimately, when intinad O care
- 20:09Speaker 4: and HIV education are both accessible, timely and culturally responsive,
- 20:15Speaker 4: they become powerful tools for improving health outcomes, not just
- 20:19Speaker 4: for women but for their families and communities as a whole.
- 20:23Speaker 2: That's really interesting, Like the overall conversations that we've had
- 20:27Speaker 2: and we're still having even in the United States, is
- 20:29Speaker 2: that comprehensive sexual and reproductive education really can make a
- 20:35Speaker 2: giant difference if allowed. And this is like obvious in
- 20:39Speaker 2: every other country, but yet even here in the US,
- 20:42Speaker 2: we don't acknowledge that.
- 20:44Speaker 3: I say we broadly, we'll leave it to that.
- 21:00Speaker 1: Well, one thing we love to do when we have
- 21:03Speaker 1: people who have such expertise on the show is kind
- 21:08Speaker 1: of get a peek behind the curtains and get a
- 21:12Speaker 1: better understanding of the process and kind of the personal
- 21:17Speaker 1: aspect of the process. So for you, can you tell
- 21:21Speaker 1: us what your experience was doing this research.
- 21:25Speaker 4: I found this research to be incredibly rewarding, and I
- 21:28Speaker 4: was especially impressed by Senegal's ability to use data to
- 21:32Speaker 4: guide HIV prevention efforts, specifically by them focusing resources on
- 21:38Speaker 4: key populations. These are populations at higher risks of acquiring HIV.
- 21:45Speaker 4: So key populations are disproportionately affected by HIV and they
- 21:49Speaker 4: play a critical role in reducing transmission. Overall, research shows
- 21:54Speaker 4: that when HIV prevention efforts successively reach these populations, HIV
- 21:58Speaker 4: rates decline only within those groups, but also in the
- 22:02Speaker 4: general population. In Senegal, some key populations include men who
- 22:06Speaker 4: have sex with men, female sex workers, and people who
- 22:09Speaker 4: inject drugs. These groups carry a higher burden of HIV,
- 22:13Speaker 4: but they also face significant barriers to prevention and care stigma, discrimination,
- 22:18Speaker 4: and in some cases criminalization. In Senegal, sex work is
- 22:23Speaker 4: legal and regulated. On the other hand, same sex relationships
- 22:28Speaker 4: are criminalized, and that difference has real public health consequences.
- 22:34Speaker 4: The criminalization of same sex relationships can really create barriers
- 22:39Speaker 4: to HIV prevention among men who have sex with men,
- 22:43Speaker 4: and there are a population that carries a disproportionately high
- 22:47Speaker 4: burden of HIV in Senegal. Discriminalization it can feel stigma, fear,
- 22:54Speaker 4: and it discourages people from seeking care, and it limits
- 22:57Speaker 4: access to testing, treatment and prevention services even when targeted
- 23:02Speaker 4: HIV programs exists. So overall, this entire process was very rewarding.
- 23:08Speaker 4: I learned a lot and it made me want to
- 23:12Speaker 4: explore topics more, one being sex work being legal and senegal,
- 23:17Speaker 4: another being the criminalization of same sex relationships.
- 23:22Speaker 2: Right in your time of research, did you have anything
- 23:25Speaker 2: that you would consider like roadblocks or difficulties as you
- 23:28Speaker 2: were going through this process.
- 23:31Speaker 4: I would definitely say that anyone that says they did
- 23:33Speaker 4: not have any roadblocks while they worked on their dissertation,
- 23:37Speaker 4: I am ready to present them with an award. The
- 23:40Speaker 4: answer is yes, I did have roadblocks. I would say
- 23:43Speaker 4: one of my biggest roadblocks was trying to stick to
- 23:49Speaker 4: a topic and not trying to expand it so much
- 23:53Speaker 4: that it ends up being more than one dissertation. What
- 23:58Speaker 4: I'm trying to say is, like I mentioned earlier, my
- 24:01Speaker 4: dissertation is really three different papers and one. There were
- 24:06Speaker 4: points in my study where I wanted to continue adding
- 24:09Speaker 4: various topics. As I researched more and gain an interest
- 24:14Speaker 4: for more, I wanted to add topics. So when I
- 24:18Speaker 4: learned about the criminalization of same sex relationships, I wanted
- 24:23Speaker 4: to discuss that and really take a deeper dive into
- 24:27Speaker 4: how that impacts the HIV landscape in Senegal, so I
- 24:33Speaker 4: did discuss it in my dissertation. However, I didn't make
- 24:36Speaker 4: it a completely separate topic. I also wanted to discuss
- 24:40Speaker 4: sex work and how sex work is legalized and this
- 24:44Speaker 4: impact on the HIV landscape and how it facilitates with
- 24:50Speaker 4: first of all, treating HIV amongst a population that is
- 24:56Speaker 4: a key population in the country, and how it all
- 25:00Speaker 4: soul support with the population overall. So there was a
- 25:07Speaker 4: lot that I found that I wanted to take a
- 25:09Speaker 4: deeper dive in. However, I have a great committee I have.
- 25:14Speaker 4: I had a committee of three people, and I had
- 25:17Speaker 4: a wonderful cheer as well. Everybody was supportive, and my
- 25:20Speaker 4: chair really allowed me to see that the dissertation is
- 25:23Speaker 4: not the end of the road. It's just the beginning.
- 25:26Speaker 4: So there's a lot more that I can write on.
- 25:29Speaker 4: Even after submitting the dissertation, there's more than I can publish.
- 25:33Speaker 4: There's more that will be done. This is only the beginning,
- 25:36Speaker 4: and you know, I really wanted to do other topics,
- 25:39Speaker 4: but I just did not have the time. I would
- 25:42Speaker 4: be working on this dissertation for like ten years if
- 25:45Speaker 4: I wanted to cover the entire ground. I wanted to cover,
- 25:47Speaker 4: there was just not enough time. The chair of my
- 25:50Speaker 4: dissertation committee, so this is the person that leads a
- 25:53Speaker 4: dissertation committee. The committee had three people, all very supportive
- 26:00Speaker 4: throughout the entire process. So my chair did a really
- 26:03Speaker 4: good job at also keeping me focused and reminding me
- 26:08Speaker 4: that I should try to tailor my dissertation to specific
- 26:12Speaker 4: topics and try to keep it together because expanding too
- 26:15Speaker 4: much can really take my dissertation to a whole nother level,
- 26:21Speaker 4: and that wasn't necessary. Furthermore, it will take more time,
- 26:25Speaker 4: like I discussed earlier, and there just was not enough time.
- 26:28Speaker 4: I will continue need you to focus exactly we needed to,
- 26:32Speaker 4: And he even said we can publish later. We can
- 26:36Speaker 4: publish later on various topics, but for this specific dissertation,
- 26:40Speaker 4: let's focus. And I that was a great idea.
- 26:43Speaker 2: Well, obviously you kind of already mentioned something that you
- 26:45Speaker 2: wanted to expand with. Is there other things, like have
- 26:49Speaker 2: you already kind of started an outline.
- 26:51Speaker 3: Of like this is the next step for this research.
- 26:56Speaker 4: I haven't started an outline of next steps per se. However,
- 27:00Speaker 4: I do have like there's a section where I talk
- 27:05Speaker 4: about what other studies can go into and that could
- 27:10Speaker 4: be either for me or for the next researcher, and
- 27:14Speaker 4: talked about how I looked at the number of anti
- 27:17Speaker 4: natocare visits that women received, and the World Health Organization
- 27:21Speaker 4: recommendation is eight or more. So I didn't look into
- 27:25Speaker 4: what services that were actually received during each visit. So
- 27:29Speaker 4: I know, let's say someone received eight visits, that's great,
- 27:33Speaker 4: but what services did this person actually received during the
- 27:37Speaker 4: eight visits and were those the services that were needed
- 27:41Speaker 4: or was something missing? So I think there are other
- 27:44Speaker 4: sections I can dive into an addition to what I've
- 27:48Speaker 4: already done.
- 27:50Speaker 2: In addition, like you're not you haven't done a giant
- 27:52Speaker 2: amount of work already.
- 27:53Speaker 3: I love that.
- 27:54Speaker 2: I was just asking because you seem to have already
- 27:56Speaker 2: like an idea of where it was all Going back
- 28:00Speaker 2: with the research, is that something that surprised you doing
- 28:03Speaker 2: your research or something that you discovered that you didn't
- 28:05Speaker 2: know outside of you. I know you talked about the
- 28:07Speaker 2: same sex and what was legal and what wasn't legal.
- 28:10Speaker 4: Yes, outside of that, I'm trying to think what else
- 28:14Speaker 4: surprised me. I think those two would be the big pieces. Yes,
- 28:20Speaker 4: as far as what surprised me, But I will say,
- 28:22Speaker 4: although this was not surprising, I did unexpectedly find out
- 28:27Speaker 4: more about like their HIV AIDS communications because that was
- 28:32Speaker 4: I was wondering how they're communicating to the general population
- 28:37Speaker 4: about HIV AIDS, and doing that, I really went into
- 28:41Speaker 4: a rabbit hole and almost wanted to write another paper
- 28:45Speaker 4: on this, but of course I didn't. Yes, But doing that,
- 28:49Speaker 4: I learned like they have a very very strong way
- 28:52Speaker 4: of communicating to the public. It's done in schools, it's
- 28:57Speaker 4: done within religious institutions. The Ministry of Health even works
- 29:05Speaker 4: with religious leaders to educate them about HIVAS and ask
- 29:10Speaker 4: them to educate their people. It's like a community effort.
- 29:15Speaker 4: I thought that was interesting that they're actually working really
- 29:17Speaker 4: well with the community for this education.
- 29:22Speaker 1: So you've kind of touched on this already, and I
- 29:25Speaker 1: think that you know, hopefully there's a lot of reasons
- 29:29Speaker 1: why this is obvious to people, But can you tell
- 29:34Speaker 1: us why this type of research is so important for
- 29:37Speaker 1: the health of women and pregnant people internationally?
- 29:42Speaker 4: Absolutely, I think that this is super important because if
- 29:48Speaker 4: we want to know how to keep someone healthy, so
- 29:52Speaker 4: I'm focusing on antenato care, if we want to know
- 29:54Speaker 4: how to keep someone healthy. How to keep women healthy
- 29:58Speaker 4: while they are bringing into the world a new life.
- 30:01Speaker 4: We really need to understand how that can happen. So
- 30:06Speaker 4: we already know that anti natal care is important. Research
- 30:10Speaker 4: has showed it. We know that. We know that having
- 30:13Speaker 4: eight or more visits is critical, having the visit being
- 30:16Speaker 4: in the first trimester is critical. So we know all that.
- 30:19Speaker 4: Now the question is, well, why isn't this happening. It's
- 30:23Speaker 4: more than just oh, the person doesn't can't afford it.
- 30:27Speaker 4: Access is more than just being able to afford something.
- 30:29Speaker 4: There can be systems in place where actually the government
- 30:33Speaker 4: provides provides these services for you. And that's something I
- 30:38Speaker 4: didn't mention that Senegal has a great way of providing
- 30:42Speaker 4: important antenatal care services to women, which is very important
- 30:48Speaker 4: because it increases access. So I think this is important
- 30:51Speaker 4: to know what's working and what's not working, and it
- 30:56Speaker 4: really helps keeping people healthy. And that's the goal.
- 31:00Speaker 3: How do we keep people healthy right?
- 31:03Speaker 2: And that is caring for both the mother and the infant,
- 31:06Speaker 2: like understanding the bigger picture and education and making sure
- 31:11Speaker 2: that people have access to information, which is such a
- 31:15Speaker 2: huge part of.
- 31:17Speaker 3: Any type of healthcare.
- 31:18Speaker 2: And with that, I feel like we have to talk
- 31:21Speaker 2: about the fact that we often see women and especially
- 31:24Speaker 2: women of color, being left out of important research like this,
- 31:29Speaker 2: And obviously y'all tapped in and making sure that we
- 31:34Speaker 2: did see some bigger picture and better research in this.
- 31:37Speaker 2: In your experience with people like you, have you seen
- 31:41Speaker 2: that change where we're actually including marginalized people into this conversation.
- 31:47Speaker 4: So for the type of work I do, we do
- 31:50Speaker 4: include marginalized populations. For the type of research that this was,
- 31:57Speaker 4: they use us like they use the sensus to really
- 32:02Speaker 4: understand the different populations, the different regions and make sure
- 32:06Speaker 4: that the survey was representative of the entire country. So
- 32:10Speaker 4: for this specific study, Yes, speaking of other studies, I
- 32:15Speaker 4: can't really speak on that behalf. But what I can
- 32:17Speaker 4: say just in general for women, especially black women for
- 32:22Speaker 4: those who don't know, I'm a black woman, So especially
- 32:26Speaker 4: for black women, there have been many times where like
- 32:30Speaker 4: the implementation of research, often it left us out, Like
- 32:36Speaker 4: we have often been underrepresented in clinical and scientific studies.
- 32:41Speaker 4: That's due to like multiple factors, but strecchal inequities is
- 32:45Speaker 4: one and we're just excluded and this this is harmful
- 32:51Speaker 4: to our health and well being. You can't generalize findings,
- 32:55Speaker 4: research findings.
- 32:56Speaker 5: If you're missing key people for these studies.
- 33:12Speaker 2: You've been in this field for sixteen years. Do you
- 33:14Speaker 2: feel like it's changed at all since the beginning?
- 33:17Speaker 4: That is a good question.
- 33:19Speaker 3: Yes, that's a big question.
- 33:22Speaker 6: It is a huge question. Do I feel that it
- 33:26Speaker 6: has changed. I think there's constant change in this field opening.
- 33:33Speaker 4: Whether we're talking about numbers, whether we're talking about like
- 33:37Speaker 4: the incidents, which is like new cases of HIV for instance,
- 33:41Speaker 4: or the prevalence, like the overall numbers. The prevalence, depending
- 33:47Speaker 4: on the region, is either increasing or decreasing. And I
- 33:52Speaker 4: wanted to mention that for incidents as well, it really
- 33:55Speaker 4: depends on the region. For instance, we see in the
- 33:59Speaker 4: Global Nor for the United States, for instance, we've seen
- 34:03Speaker 4: a lot of improvements. However, there's certain areas where we
- 34:06Speaker 4: are still having challenges. Atlanta, where we reside, is one area,
- 34:11Speaker 4: and we also see the same in the Global South,
- 34:14Speaker 4: and specifically if I'm focusing on Sub Saharan Africa, we
- 34:18Speaker 4: do have populations that in various countries that are still
- 34:23Speaker 4: having challenges. For instance, I talked about key populations. These
- 34:27Speaker 4: are like the sex workers, men who have sex with men,
- 34:30Speaker 4: and other people who inject drugs, and other key populations
- 34:35Speaker 4: that are disproportionately impacted by HIV, so we do see
- 34:40Speaker 4: improvements in some regions. In some regions we've seen improvements
- 34:44Speaker 4: and then we've seen a reversal as well. Globally, however,
- 34:50Speaker 4: we've made a remarkable and measurable progress in the fight
- 34:54Speaker 4: against HIV, but challenges still remain. Over the past few decades, AIDS,
- 35:01Speaker 4: we've seen new HIV infection, so the end CHIV incidents
- 35:06Speaker 4: and age related deaths have dropped drastically. We can attribute
- 35:11Speaker 4: a lot of these successes to expanded access to testing, treatment,
- 35:16Speaker 4: and life saving antiretroviral treatment. According to UNA's and the
- 35:22Speaker 4: World Health Organization, new infections have really declined more than
- 35:27Speaker 4: half since the peak of HIV in the mid nineteen nineties,
- 35:33Speaker 4: and AIDS related deaths have also fallen to about seventy percent.
- 35:39Speaker 4: They've fallen about seventy percent since the early two thousands.
- 35:43Speaker 4: I mentioned this earlier, but one of the critical pieces
- 35:47Speaker 4: to this is prevention and treatment anti retroviral therapy. It's
- 35:54Speaker 4: really has changed the game and transformed HIV from a
- 35:57Speaker 4: fatal disease into a more manageable chronic condition, and there
- 36:02Speaker 4: are tens of millions of people around the world today
- 36:06Speaker 4: on treatment and that allows them to live long, healthy lives.
- 36:11Speaker 4: And the treatment actually suppresses the virus, it prevents transmission.
- 36:16Speaker 4: So there's a concept called you equals you. It's undetectable untransmittable.
- 36:21Speaker 4: So for people that are on treatment and the treatment
- 36:26Speaker 4: works effectively for them and they take the medication as prescribed,
- 36:32Speaker 4: they can become undetectable. This means that their viral load
- 36:37Speaker 4: and their body is so low that it is undetectable.
- 36:41Speaker 4: So what I'm really trying to say is overall, we
- 36:43Speaker 4: have seen progress because of data driven and targeted approaches
- 36:49Speaker 4: that focus prevention and care efforts on populations at hy risk.
- 36:53Speaker 4: We call these the key populations, and we see that
- 36:57Speaker 4: when we combine strong health systems, community engagement, HIV outcomes,
- 37:04Speaker 4: and we really focus to improve the health and wellbeing
- 37:08Speaker 4: of people through the entire population. This works because if
- 37:15Speaker 4: you focus on improving one's health, it really helps improve
- 37:22Speaker 4: the health of everyone. We talked about this briefly with
- 37:25Speaker 4: sex workers, legalizing sex work and preventing HIV and providing
- 37:31Speaker 4: treatment for people in with HIV, engage in sex work
- 37:35Speaker 4: that really protects the entire community. So we've seen progress overall,
- 37:42Speaker 4: but it's not the same progress all over. There are
- 37:46Speaker 4: gaps that still remain. Some of the gaps are due
- 37:49Speaker 4: to stigma and legal barriers and funding challenges, and these
- 37:52Speaker 4: definitely impact women, young people, and key populations overall. What
- 37:59Speaker 4: we know is is that when science pausing equity comes together,
- 38:04Speaker 4: progress has been made and that's really an important lesson
- 38:07Speaker 4: for public health going forward.
- 38:10Speaker 2: Yeah, I know in Florida they have made it a
- 38:14Speaker 2: little more difficult for those who have been going through
- 38:17Speaker 2: treatment HIV and age treatment to getting their medication because
- 38:21Speaker 2: of the new administration and things that are happening, which
- 38:23Speaker 2: is really unfortunate. You like, for a minute, it feels
- 38:27Speaker 2: like everything was okay and we were like, oh, we're
- 38:29Speaker 2: getting better, we're acknowledging, we're normalizing treatment, we're having a conversation.
- 38:33Speaker 2: All of a sudden we have all like a rollback,
- 38:35Speaker 2: and you're like, oh no, we got to figure out
- 38:39Speaker 2: this out.
- 38:39Speaker 3: We got to keep talking about it.
- 38:40Speaker 2: We got to keep making this conversation, which is why
- 38:42Speaker 2: work like yours is so important. And seeing countries like
- 38:47Speaker 2: Senegal being able to be a light and be like, Hey,
- 38:51Speaker 2: we can do this if we just keep on track.
- 38:54Speaker 4: So this is an interesting topic and I am not
- 39:00Speaker 4: like the policy expert for US policies for HIV. However,
- 39:06Speaker 4: this topic is very important and from the basic imbond
- 39:14Speaker 4: of information that I know, I did learn about that.
- 39:19Speaker 4: I did learn how Florida has restricted access to their
- 39:23Speaker 4: Age Drug Assistance Program ADAP and they've changed eligibility requirements,
- 39:29Speaker 4: and they've also removed big TARV from the coverage, and
- 39:35Speaker 4: there are other changes that were made which are very
- 39:37Speaker 4: concerning to me because it limits access to life saving
- 39:40Speaker 4: drugs and this is needed for HIV prevention and treatment.
- 39:48Speaker 4: So this type of decision impacts the lives and the
- 39:52Speaker 4: well being of people living with HIV. I feel like
- 39:56Speaker 4: this change really shows us how policy and funding this
- 40:00Speaker 4: decisions can quickly disrupt and interrupt access to life saving
- 40:05Speaker 4: HIV treatment in a high income setting.
- 40:09Speaker 3: It's a lot fun fact.
- 40:11Speaker 2: I found out that the Asian people's my people's I
- 40:16Speaker 2: am missing an enzyme that causes me to turn very
- 40:18Speaker 2: bright red sometimes with alcohol, to the point that looks
- 40:22Speaker 2: like I'm not having an allergic reaction. I found out
- 40:24Speaker 2: that that actually affects a lot of the medications that
- 40:27Speaker 2: we are prescribed, and a lot of.
- 40:29Speaker 3: Doctors don't know that.
- 40:32Speaker 2: This is going back to like the marginalized people who
- 40:34Speaker 2: were like not noted being part of the research. They
- 40:38Speaker 2: really just like slapped on to be like white people
- 40:40Speaker 2: can do this, so everybody else like this. And I
- 40:43Speaker 2: found out, I'm like, oh, really, I did not. Really,
- 40:46Speaker 2: you're not supposed to have certain medications like heart blood
- 40:49Speaker 2: pressure medications, like it's not effective from Asian some Asian
- 40:53Speaker 2: people because of the enzymes. And I was like, well, damn,
- 40:57Speaker 2: why didn't I know about this earlier.
- 40:59Speaker 3: I'm into that.
- 41:00Speaker 4: Absolutely, any Absolutely, I think it's important.
- 41:04Speaker 3: To put myself in here.
- 41:05Speaker 4: No, No, you're completely right. I think it's important to
- 41:08Speaker 4: That's why we need to be included in the relevant
- 41:11Speaker 4: research studies. That's all important.
- 41:13Speaker 2: Yes, come on, come on what you're doing and we
- 41:17Speaker 2: are very very grateful for obviously.
- 41:21Speaker 4: Thank you.
- 41:24Speaker 1: So you've talked about some of the future ideas you
- 41:27Speaker 1: have of what you're going to do, But what is
- 41:30Speaker 1: what is your hope for the future with this type
- 41:34Speaker 1: of work that you're doing.
- 41:37Speaker 4: Yes, So, what I would really like to see come
- 41:42Speaker 4: out of this I want to see more cross sector
- 41:47Speaker 4: approaches to improving the health and wellbeing of populations. So
- 41:52Speaker 4: when I say cross sector, I'm talking about different different agencies,
- 41:58Speaker 4: different groups working together. So the religious leaders, the ministries
- 42:02Speaker 4: of health, the education departments, all of these, even transportation,
- 42:08Speaker 4: transportation is critical to accessing healthcare. The medical professionals, the
- 42:12Speaker 4: public health people, all of us sitting at the round
- 42:15Speaker 4: table and discussing this together and seeing how we can
- 42:19Speaker 4: combat all and this isn't just HIV, how we can
- 42:23Speaker 4: combat any illness, any disease, how we can help people
- 42:27Speaker 4: live happy and healthy lives. I feel like even in
- 42:31Speaker 4: creating policies, we should be considering there's a concept called
- 42:38Speaker 4: health in all policies, and this health and all policies
- 42:43Speaker 4: make sure that all the right people are at the
- 42:45Speaker 4: table when we're making policies, because all too often policies
- 42:49Speaker 4: are made and then we're like, whoops, we forgot something.
- 42:52Speaker 4: So I would like to see that when decisions are made,
- 42:55Speaker 4: when policies are made, the right people are at the
- 42:58Speaker 4: right table. Oh and when I'm saying the right people
- 43:02Speaker 4: left out by XM one important population, we should have
- 43:04Speaker 4: people living with AIDS at the table, people live with
- 43:07Speaker 4: HIV at the table, who best to advocate for themselves
- 43:11Speaker 4: and say what they need other than these people. And
- 43:14Speaker 4: then when we're talking about pregnant people or anything about
- 43:20Speaker 4: women's health, like women should be at the table. Pregnant
- 43:22Speaker 4: people should be at the table. So let's be inclusive.
- 43:26Speaker 2: Yes, yes, that's the big statement, Like that's such a
- 43:32Speaker 2: level of understanding that we're not going to understand how
- 43:35Speaker 2: to treat it if the people who are not affected
- 43:38Speaker 2: by it are not.
- 43:39Speaker 3: At the table.
- 43:40Speaker 2: That is such a big conversation that we need to
- 43:43Speaker 2: have repeatedly and often in this kind of research, in
- 43:47Speaker 2: any research, in any job, that we need to have
- 43:51Speaker 2: those people being present. Oh you're doing a lot of work,
- 43:55Speaker 2: they see, and I appreciate doctor Detto. I'm coming back,
- 43:59Speaker 2: and we preciate you taking your time and coming to
- 44:02Speaker 2: talk to us about your work because we want to
- 44:04Speaker 2: be able to have a bigger conversation of what this
- 44:07Speaker 2: looks like, how this impacts so many people, and what
- 44:11Speaker 2: we can do in order to make sure this conversation
- 44:15Speaker 2: is getting out there. So we definitely appreciate that. Now
- 44:19Speaker 2: we want to bring it back because this is a
- 44:22Speaker 2: lot and I remember again just watching you having to
- 44:25Speaker 2: do through go through all the work and presenting your
- 44:28Speaker 2: dissertation and all of that, I have to ask, how
- 44:32Speaker 2: do you take time for yourself and what do you
- 44:35Speaker 2: do for like yourself and and self care?
- 44:39Speaker 4: That is a great question. So number one on the
- 44:43Speaker 4: list is Zoomba.
- 44:46Speaker 3: Yeah, that's right.
- 44:49Speaker 4: Absolutely, I love Zoomba. I probably do zoombam. I do
- 44:54Speaker 4: zombo mouncicle times a week, so love it. I just
- 44:57Speaker 4: got into pilates, which I'm like a newbie. Love it
- 45:01Speaker 4: as well. I love to just hang out with my friends,
- 45:06Speaker 4: whether we're just at a coffee shop anywhere really we're shopping,
- 45:11Speaker 4: whatever we do, we always have a good time talking
- 45:15Speaker 4: catching up. Yeah. So just spending time with friends, loved ones.
- 45:20Speaker 4: That's really what I do.
- 45:22Speaker 3: And I like to look your jet setter too, like
- 45:25Speaker 3: you trying.
- 45:26Speaker 4: Oh yeah, I do travel, yes, that is that is
- 45:30Speaker 4: another passion of mine. Yes, I'd love to travel.
- 45:33Speaker 3: I love seeing those pictures.
- 45:35Speaker 2: I'm like, oh, look she's there on the beach or
- 45:37Speaker 2: with the you know, being all fancy in her background
- 45:41Speaker 2: of like wherever you are that day. I'm like, that's nice.
- 45:45Speaker 2: I get jealous, absolutely.
- 45:47Speaker 3: I look at her. I get jealous.
- 45:50Speaker 4: To put your in a suitcase.
- 45:51Speaker 3: We talked about that. We're like, we gotta do something right.
- 45:54Speaker 1: Yes, yes, well, thank you, thank you so much for
- 46:01Speaker 1: being here. We would love to have you back and
- 46:04Speaker 1: check in later see what you're up to. But before
- 46:11Speaker 1: before we close out completely, where can the good listeners
- 46:15Speaker 1: find you?
- 46:15Speaker 2: Do you?
- 46:16Speaker 1: Do you have anything you want to shout out? Yeah?
- 46:19Speaker 4: Absolutely so. Samantha just mentioned I'd love to travel. I
- 46:22Speaker 4: actually have an Instagram It's called Her Boarding Pass. It's
- 46:26Speaker 4: all one word, just the word her, then the word
- 46:30Speaker 4: boarding and then pass, all one word. So you can
- 46:33Speaker 4: find me there.
- 46:35Speaker 3: See her travels and be jealous with me.
- 46:37Speaker 1: Yes, yes, listeners do that. Well, thank you so much
- 46:44Speaker 1: again for being here. It was a wonderful conversation. If
- 46:48Speaker 1: you would like to contact us, you can or email
- 46:50Speaker 1: is hello at stuff I've Never Told You dot com.
- 46:52Speaker 1: We're also on blue Skype, Mom Stuff podcast, or on
- 46:54Speaker 1: Instagram and TikTok at stuff I've Never told You.
- 46:56Speaker 4: We have a YouTube channel.
- 46:59Speaker 1: We have some merchandice at Coppon Bureau, and we have
- 47:01Speaker 1: a book you can get where if you get your book,
- 47:04Speaker 1: Thanks as always to a superducer Christina Executive Prus.
- 47:06Speaker 4: And Maya and our Contrbudor Joey.
- 47:08Speaker 1: Thank you and thanks to you for listening Stuff Never
- 47:10Speaker 1: Told You Instruction by Heart Radio. For more podcast from
- 47:12Speaker 1: my Heart Radio, you can check out the iHeart Radio app,
- 47:14Speaker 1: Apple podcast, or wherever you listen to your favorite shows.